简介：Eiger BioPharmaceuticals, Inc.于2016年3月22日由Celladon Corporation和BioPharmaceuticals, Inc.合并而成。BioPharmaceuticals, Inc.在美国加州注册，于2000年12月21日成立，并于2012年4月在特拉华州重新合并，该公司是一家商业阶段的生物制药公司，专注于开发针对德尔塔病毒（HDV）和其他严重疾病的创新疗法。在他们的投资组合中，他们所有的罕见病项目都被美国食品药品监督管理局指定为突破疗法。
| 今开： | 昨收：1.15 |
| 最高： | 最低： |
| 涨停价： | 跌停价： |
| 总市值：39835866.6 |
医药魔方2020-06-23 19:16
6月23日，总部位于美国芝加哥的Sparx Therapeutics公司在AACR-2020年会上首次公布了其抗蜜蛋白18剪切变体2（claudin18.2或者CLDN18.2）抗体（Abstract#3361）和CLDN18.2/PD-L1双特异抗体（Abstract# 534）的临床前结果。后者是目前为止全球首个抗CLDN 18.2/PD-L1双特异抗体。该研究由Sparx Therape...查看全文
earning2015-12-13 07:19
$Celladon Corporation(CLDN)$ 看线破1是稳稳地[看空]还有人持有？查看全文
Nicole07772015-12-05 03:34
$Celladon Corporation(CLDN)$ I'll buy the share after M&A with Eiger BioPharmaceuticals. No company name of Celladon Corp.查看全文
亲民的盈利小啄木鸟2015-12-03 23:03
$Celladon Corporation(CLDN)$盘前盘后就是个坑查看全文
股市怪盗2015-12-02 23:02
$Great Basin Scientific, Inc.(GBSN)$ 看着这行情 我觉得更该坚定持有$Celladon Corporation(CLDN)$ 专治心脏衰竭![[大笑]](https://assets.imedao.com/ugc/images/face/emoji_02_laughing.png?v=1 "[大笑]"){kind=small}
查看全文
股市怪盗2015-12-01 22:04
今天继续 三体合一[跪了]$Great Basin Scientific, Inc.(GBSN)$ $NET ELEMENT INTL INC(NETE)$ $Celladon Corporation(CLDN)$查看全文
奇米夫2015-12-01 04:15
$Celladon Corporation(CLDN)$ 1.60进 1.69出。。。。。。。涨的太快 卖的太快![[哭泣]](https://assets.imedao.com/ugc/images/face/emoji_09_cry.png?v=1 "[哭泣]"){kind=small}
查看全文
Nicole07772015-11-26 04:35
Nicole07772015-11-26 02:13
$Celladon Corporation(CLDN)$ Very welcome M&A with Eiger BioPharmaceuticals.
Eiger BioPharmaceuticals is seems like very nice company.查看全文
$Celladon(CLDN)$ 8-K - Current report Filed: 2019-11-07 AccNo: 0001193125-19-287307 Size: 90 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Celladon(CLDN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-07 AccNo: 0001564590-19-041773 Size: 7 MB 网页链接
$Celladon(CLDN)$ 8-K - Current report Filed: 2019-08-08 AccNo: 0001193125-19-216853 Size: 87 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Celladon(CLDN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-08 AccNo: 0001564590-19-030837 Size: 6 MB 网页链接
$Celladon(CLDN)$ 8-K/A [Amend] - Current report Filed: 2019-08-08 AccNo: 0001193125-19-217043 Size: 88 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Celladon(CLDN)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-06-14 AccNo: 0000919574-19-004168 Size: 109 KB 网页链接
$Celladon(CLDN)$ 8-K - Current report Filed: 2019-06-12 AccNo: 0001193125-19-171309 Size: 25 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Celladon(CLDN)$ 8-K - Current report Filed: 2019-05-17 AccNo: 0001193125-19-150558 Size: 19 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Celladon(CLDN)$ 8-K - Current report Filed: 2019-05-09 AccNo: 0001193125-19-142983 Size: 79 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Celladon(CLDN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-09 AccNo: 0001564590-19-018009 Size: 5 MB 网页链接